New radio therapy treatment for cancer patients

The video discusses a new form of radiotherapy called Intrabeam, which offers a one-time radiation dose during surgery for early breast cancer patients. This method is more convenient and targets cancer cells more precisely, reducing damage to healthy tissue. Although provisionally approved by the NHS, further data collection is required to understand its long-term effects. Currently available in six hospitals, it has the potential to treat 36,000 patients annually if expanded.

What is the advantage of the new form of radiotherapy called Intrabeam?

How does the new localized radiotherapy reduce damage to healthy tissue?

What are the conditions set by Nice regarding the new treatment?

Why is it important for patients to be made aware of the outcomes data before making a decision?

What is the estimated number of patients that could be suitable for the new treatment each year?